share

5-(7-(3-Bromophenyl)-[1,2,4]Triazolo[1,5-A]Pyrimidin-6-Yl)-3-Methylisoxazole CAS NO 1416374-63-4


Unit Price:

CAS No.:1416374-63-4

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

5-(7-(3-Bromophenyl)-[1,2,4]Triazolo[1,5-A]Pyrimidin-6-Yl)-3-Methylisoxazole is a high-purity, advanced pharmaceutical intermediate designed for precision synthesis. This compound is valued for its role as a critical building block in the development of novel active pharmaceutical ingredients (APIs), particularly in kinase inhibitor research. It is primarily sought by R&D laboratories and production facilities in the pharmaceutical and biotechnology sectors engaged in innovative drug discovery programs.

Application

  • Pharmaceutical Intermediate: A key synthetic precursor in the research and development of new therapeutic agents.
  • Kinase Inhibitor Synthesis: Serves as a core scaffold for constructing potent and selective kinase inhibitors targeting various disease pathways.
  • Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization processes.
  • Biochemical Tool Compound: Employed in biochemical assays and pharmacological studies to investigate specific biological targets.
  • Custom Synthesis: Utilized by contract research and manufacturing organizations (CROs/CMOs) for client-specific molecule development.
  • Academic Research: Supports chemical biology and drug discovery projects in university and institutional laboratories.

Basic Information

Product Name 5-(7-(3-Bromophenyl)-[1,2,4]Triazolo[1,5-A]Pyrimidin-6-Yl)-3-Methylisoxazole
CAS No. 1416374-63-4
Molecular Formula C15H10BrN5O
Molecular Weight 356.18 g/mol
Synonyms 5-[7-(3-Bromophenyl)-[1,2,4]triazolo[1,5-a]pyrimidin-6-yl]-3-methylisoxazole; 3-Methyl-5-(7-(3-bromophenyl)-[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)isoxazole; 1416374-63-4; BPTMPI; 5-(7-(3-Bromophenyl)-[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)-3-methyl-1,2-oxazole
EINECS Contact for details

Quality Control

Our 5-(7-(3-Bromophenyl)-[1,2,4]Triazolo[1,5-A]Pyrimidin-6-Yl)-3-Methylisoxazole is manufactured under strict quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC, NMR, and mass spectrometry, to ensure identity, purity, and consistency. A detailed Certificate of Analysis (COA) is provided with each shipment, confirming the product meets the agreed-upon specifications for pharmaceutical R&D use.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). The compound may be light-sensitive and should be handled accordingly to maintain stability.

Specification

Item Specification
Appearance Off-white to light yellow solid
Identification (HPLC) Conforms
Identification (NMR) Conforms
Purity (HPLC) ≥ 97.0%
Water Content (KF) ≤ 0.5%
Residue on Ignition ≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

why choose us

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.